AquaBounty seeks Canadian approval for biotech salmon

AquaBounty Technologies has taken the initial steps to seek approval in Canada for its biotech salmon as it awaits an FDA panel's review of the product. AquaBounty President and CEO Ronald Stotish said the Canadian application is in its early stages, but the company is "very interested because of our strong presence" in the country.

View Full Article in:

Gazette (Montreal) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA